Therapies for Cancer

OR38-1

Hyperglycemia Inhibits the Anti-Cancer Effects of Metformin
Lacey M Litchfield, Mohammed Habis, Nadia Ismail, Alyssa Johnson, Ernst Lengyel and Iris L Romero

OR38-3

A Selective Estrogen Receptor Beta Antagonist Reverses Tamoxifen Resistance and Augments Chemotherapy-Induced Cytotoxicity in Breast Cancer
Ali A Pedram, Mahnaz Razandi, Suzanne A Fuqua, Ramesh Narayanan, James Dalton and Ellis R Levin

OR38-4

Estrogen Receptor Beta: A Prognostic Biomarker and Novel Therapeutic Drug Target in Breast Cancer
Jordan M Reese, Vera J Suman, Malayannan Subramaniam, Xianglin Wu, Vivian Negron, Anne Gingery, Kevin S. Pitel, Sejal S Shah, Heather E Cunliffe, Ann E McCullough, Barbara A Pockaj, Fergus J Couch, Janet E Olson, Carol Reynolds, Wilma L Lingle, Thomas C Spelsberg, Matthew P Goetz, James N Ingle and John R Hawse

OR38-5

Expression and Therapeutic Targeting of Dopamine Receptor Type-1 in Breast Cancer
Dana C Borcherding, David F Barnard, Eric R Hugo, Sejal R Fox, Kathleen LaSance and Nira Ben-Jonathan

OR38-6

In Vivo Imaging of Mesenchymal Stem Cell Recruitment into the Tumor Stroma of Hepatocellular Carcinoma (HCC) Using a HIF-Specific Sodium Iodide Symporter (NIS) Gene System
Kerstin Knoop, Andrea Maria Mueller, Kathrin A Schmohl, Nathalie Schwenk, Janette Carlsen, Marcus Hacker, Burkhard Göke, Ernst Wagner, Peter J Nelson and Christine Spitzweg